Abstract

Because of weight gain, women often discontinue hormonal contraception, especially depot medroxyprogesterone acetate (DMPA). Our objective was to conduct a systematic review of studies describing dietary intake or eating behavior in DMPA users to understand whether the use of DMPA is associated with changes in dietary habits and behaviors leading to weight gain. We searched the PubMed, POPLINE, CENTRAL Cochrane, Web of Science, and EMBASE databases for reports published in English between 1980 and 2017 examining dietary intake or eating behavior in healthy women in reproductive age and adolescents using DMPA (150 mg/mL). Of the 749 publications screened, we excluded 742 due to duplicates (96), not addressing the key research question (638), not reporting dietary intake data (4), and not evaluating the relationship of body weight and dietary or eating behaviors (4). We identified seven relevant studies, including one randomized placebo-controlled trial, one non-randomized paired clinical trial, and five cohort studies. The randomized trial found no association and the other reports were inconsistent. Findings varied from no change in dietary intake or eating behavior with DMPA use to increased appetite in the first six months of DMPA use. Few studies report dietary intake and eating behavior in DMPA users and the available data are insufficient to conclude whether DMPA use is associated with changes in dietary habits or behavior leading to weight gain.

Highlights

  • One of the most highly effective forms of reversible contraception is depot medroxyprogesterone acetate (DMPA)

  • The goal of this systematic review was to summarize studies that address whether use of DMPA is associated with changes in dietary habits and eating behaviors leading to weight gain

  • Investigators evaluated dietary intake and eating behavior in DMPA users in an attempt to elucidate the possible mechanism of the association between DMPA use and weight variation [7,8,13,16]

Read more

Summary

Introduction

One of the most highly effective forms of reversible contraception is depot medroxyprogesterone acetate (DMPA). This progestin-only injectable contraceptive is administered quarterly and works by suppressing ovulation [1]. There are a number of reports in the medical literature that seek to identify mechanisms to explain weight gain in DMPA users [8,11,12,13,14,15]. Some studies reported changes in dietary intake or eating behavior with DMPA use [7,8,13,16,17]. The goal of this systematic review was to summarize studies that address whether use of DMPA is associated with changes in dietary habits and eating behaviors leading to weight gain

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.